# MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

> **NCT00090064** · PHASE2 · COMPLETED · sponsor: **Resilient Pharmaceuticals** · enrollment: 23 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Midomafetamine HCl
- **DRUG:** Lactose placebo pill
- **BEHAVIORAL:** Therapy

## Key facts

- **NCT ID:** NCT00090064
- **Lead sponsor:** Resilient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-12
- **Primary completion:** 2008-05-02
- **Final completion:** 2010-06-21
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090064, "MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*